Baoxia Dong

机构：Shanghai Jiao Tong University, Shanghai First People's Hospital

发表论文 36 篇 · 总被引 122 次 · h-index 5

代表论文

• Circular mRNA-based TCR-T offers a safe and effective therapeutic strategy for treatment of cytomegalovirus infection (2023 · Molecular Therapy · 被引 33)
• CD19/CD22 bispecific CAR-T cells for MRD-positive adult B cell acute lymphoblastic leukemia: a phase I clinical study (2023 · Blood Cancer Journal · 被引 26)
• Low-dose anti-thymocyte globulin plus low-dose post-transplant cyclophosphamide-based regimen for prevention of graft-versus-host disease after haploidentical peripheral blood stem cell transplants: a large sample, long-term follow-up retrospective study (2023 · Frontiers in Immunology · 被引 17)
• A Novel JAK1 Inhibitor SHR0302 Combined With Prednisone for First-Line Treatment of Chronic Graft-Versus-Host Disease: A Phase I Clinical Trial (2024 · Cell Transplantation · 被引 8)
• Low-dose anti-thymocyte globulin plus low-dose posttransplant cyclophosphamide-based regimen for prevention of graft-versus-host disease in haploidentical peripheral blood stem cell transplantation for pediatric patients with hematologic malignancies (2024 · Annals of Hematology · 被引 4)
• Parous female donor is not inferior to the young male donor under the low-dose ATG/PTCy combination-based regimen for GVHD prophylaxis in haploidentical peripheral blood stem cell transplantation (2025 · Leukemia Research · 被引 3)